Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.2479
+0.0479 (23.95%)
Sep 30, 2026, 9:30 AM EST
Guided Therapeutics Market Cap
Guided Therapeutics has a market cap or net worth of $23.93 million as of October 1, 2026. Its market cap has increased by 19.28% in one year.
Market Cap
23.93M
Enterprise Value
27.42M
Revenue
650.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
ChartMarket Cap Chart
Since July 1, 1997, Guided Therapeutics's market cap has decreased from 448.72M to 23.93M, a decrease of -94.67%. That is a compound annual growth rate of -9.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 23.93M | -48.56% |
| Dec 31, 2025 | 46.52M | 376.20% |
| Dec 31, 2024 | 9.77M | 17.63% |
| Dec 29, 2023 | 8.31M | -43.03% |
| Dec 30, 2022 | 14.58M | 84.30% |
| Dec 31, 2021 | 7.91M | 101.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Positron | 61.42M |
| PetVivo Holdings | 30.57M |
| Vivos | 21.67M |
| ALR Technologies SG | 11.88M |
| AI Maverick Intel | 7.83M |
| BioElectronics | 7.41M |
| Sonendo | 7.40M |
| Kelyniam Global | 7.00M |